MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    A phase 2b randomized, double-blind, placebo-controlled study of suvecaltamide in the treatment of adults with moderate to severe essential tremor: study design and methodology

    A. Sterkel, W. Ondo, R. Elble, P. Lewitt, R. Pahwa, C. Urrea, L. Huang, L. Hickey, M. Baladi (Palo Alto, USA)

    Objective: Evaluate the efficacy and safety of JZP385 (formerly CX-8998), a highly selective T-type calcium channel modulator, for symptomatic control of moderate to severe essential…
  • MDS Virtual Congress 2021

    Tremor after organ transplantation: prevalence and characteristics

    A. Stouwe, J. Elting, D. Plasmeijer, S. Bakker, G. Drost (Groningen, Netherlands)

    Objective: Here we report on the largest population of solid organ transplant recipients that was investigated with clinical neurophysiological methods, to objectively establish the tremor…
  • MDS Virtual Congress 2021

    Cerebellar Pathway Outflow Tremor from Thalamic and Midbrain Glioma Responded to Dopaminergic Therapy

    K. Yen, A. Yaworski, M. Bussiere, F. Ba (Edmonton, Canada)

    Objective: To describe a case of cerebellar pathway outflow tremor caused by denervation of the dopaminergic pathway from thalamic and midbrain glioma, which responded to…
  • MDS Virtual Congress 2020

    Regional free-water differentially associated with glial activation, neuroinflammation, and neurodegeneration in de novo Parkinson’s disease

    D. Tosun, R. Ellis (San Francisco, CA, USA)

    Objective: Assess to what extent free-water(FW) as measured by diffusion-weighted MRI(dMRI) is a neuroimaging marker of glial activation, neuroinflammation, and neurodegeneration in de novo Parkinson’s disease(PD) patients from…
  • MDS Virtual Congress 2020

    Brain atrophy progression in de novo Parkinson’s disease

    C. Tremblay, S. Rahayel, A. Vo, A. Dagher (Montreal, QC, Canada)

    Objective: Using deformation-based morphometry (DBM) as a measure of atrophy, the aim of this study was to identify the regions presenting structural brain changes after…
  • MDS Virtual Congress 2020

    Neuroimaging Extra-Striatal D2 Receptors in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder

    M. Valli, SS. Cho, M. Masellis, R. Chen, Y. Koshimori, M. Diez-Cirarda, A. Mihaescu, A. Strafella (Toronto, ON, Canada)

    Objective: Our aim was to characterize the extra-striatal dopamine in Parkinson’s disease (PD) with and without rapid eye movement sleep behaviour disorder (RBD) using in…
  • MDS Virtual Congress 2020

    Prefrontal cortical activity and the control of walking in people with freezing of gait

    R. Vitorio, S. Stuart, M. Mancini (Portland, OR, USA)

    Objective: To investigate the influence of freezing of gait (FoG) on automaticity of walking in people with Parkinson’s disease (PD). Background: A hallmark of healthy…
  • MDS Virtual Congress 2020

    Progression of cortical thinning in Parkinson’s disease

    A. Vo, C. Tremblay, S. Rahayel, Y. Yau, A. Dagher (Montréal, QC, Canada)

    Objective: We sought to validate cortical thickness as an objective biomarker of Parkinson’s disease (PD) progression. Background: Cortical thickness analysis has been proposed as a…
  • MDS Virtual Congress 2020

    Decreased Availability of Adenosine 2A Receptors in the Caudate in Patients with Early Stage Parkinson’s Disease

    I. Waggan, E. Rissanen, J. Tuisku, J. Joutsa, S. Helin, R. Parkkola, J. Rinne, L. Airas (Turku, Finland)

    Objective: The aim of this study was to investigate Adenosine 2A (A2A) receptor availability in patients with early and moderate stage Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2020

    Normative vs. patient-specific brain connectivity in Deep Brain Stimulation

    Q. Wang, H. Akram, M. Muthuraman, G. Gonzalez-Escamilla, S. A. Sheth, G. Groppa, N. Vanegas-Arroyave, L. Zrinzo, N. Li, A. Kühn, A. Horn (Berlin, Germany)

    Objective: The objective of this study was to compare similarities and differences between patient-specific, disease-matched and normative structural connectivity seeding from deep brain stimulation (DBS)…
  • « Previous Page
  • 1
  • …
  • 829
  • 830
  • 831
  • 832
  • 833
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley